Key Metrics
CiteScore 

1.9
Impact Factor 

< 5
SNIP 

0.41
Recommended pre-submission checks
Powered by 

Topics Covered on Italian Journal of Food Science
Italian Journal of Food Science Journal Specifications
Indexed in the following public directories
Web of Science
| Overview | |
| Publisher | CODON PUBLICATIONS |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 1100 |
| Publication Time | 12 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Italian Journal of Food Science ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Italian Journal of Food Science
Ocular Transient Ischemic Episode in Carotid Artery Stenosis.
- 1 May 2026
- Ophthalmology
期刊一览
- 1 May 2026
- Ophthalmology
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Ninety-Six-Week Results from the Randomized Phase 2/3 PHOTON Trial.
- 1 May 2026
- Ophthalmology
Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal COMET-2 and COMET-3 Studies.
- 1 May 2026
- Ophthalmology
Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results from the RHONE-X Extension Trial.
- 1 May 2026
- Ophthalmology
Contents
- 1 May 2026
- Ophthalmology
Ocular Transient Ischemic Episode in Carotid Artery Stenosis.
- 1 May 2026
- Ophthalmology
期刊一览
- 1 May 2026
- Ophthalmology
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Ninety-Six-Week Results from the Randomized Phase 2/3 PHOTON Trial.
- 1 May 2026
- Ophthalmology
Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal COMET-2 and COMET-3 Studies.
- 1 May 2026
- Ophthalmology
Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results from the RHONE-X Extension Trial.
- 1 May 2026
- Ophthalmology
Contents
- 1 May 2026
- Ophthalmology